Home Blog Page 2
Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer’s disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start...
A new technology has brought researchers one step closer to a future cure for Congenital Muscular Dystrophy type1A, a devastating muscle disease that affects children. The new findings are based on research by Kinga Gawlik at Lund University, Department of Experimental Medical Science, and were recently published in Nature. A new technology has brought researchers one step closer to a future...
  For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia – a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies. Now the researchers have published a study in the journal Scientific Reports that...
Indian women are younger and leaner than Swedish women when they develop gestational diabetes, a new study from Lund University shows. The researchers also found a gene that increases the risk of gestational diabetes in Swedish women, but which, on the contrary, turned out to have a protective effect in Indian women. Gestational diabetes is characterized by impaired insulin production...
Svenska Läkaresällskapet belönar seniorprofessor Åke Lernmark vid Lunds universitet med Oscar Medins pris och 25 000 kronor. Åke Lernmark inledde sin forskarkarriär inom typ 1-diabetes på 1970-talet. Han är bland annat ansvarig för den svenska delen av TEDDY-studien och TrialNet där han studerat varför vissa barn får typ 1-diabetes och inte andra. Hur känns det att få ta emot den här utmärkelsen? – Det...

Test – Pie redirect

Pie has been configured to redirect to another page if you are not logged in.
Pie has been configured to block this content if you are not logged in.

Sinntaxis

Sinntaxis was founded 2017 by scientists at Lund University and LU Holding AB. The company is managed by a team with vast experience in neuroscience/stroke research and pharmaceutical drug development and business development. There is currently no drug treatment available to help stroke patients recover brain functions. Patients are restricted to rehabilitation therapy, particularly physiotherapy and speech therapy. The discovery...
The first evidence was recently presented demonstrating how the immune system can be controlled by directly reprogramming connective tissue cells into immune cells. The discovery provides the opportunity to develop an entirely new strategy for targeted immunotherapy against cancer. One characteristic of cancer is its ability to avoid detection by the body’s immune system. Tumour cells accumulate a number of...
På senare år har forskare blivit alltmer klara över att proteinet galectin-3 är involverat vid inflammationssjukdomar i hjärnan. Nu visar en studie som letts av forskare vid Lunds universitet vilken nyckelroll proteinet de facto har vid Alzheimers sjukdom. När forskarna stängde av genen som producerar detta protein hos möss, minskade såväl mängden alzheimerplack som inflammationsbördan. Forskare vid Lunds universitet har...
- Advertisement -
- Advertisement -
- Advertisement -
WP to LinkedIn Auto Publish Powered By : XYZScripts.com